This is a preview of subscription content, log in via an institution to check access.
Reference
Lingling X, et al. Transformation of NSCLC to SCLC harboring EML4-ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review. Lung Cancer 186: no pagination, Dec 2023. Available from: URL: https://dx.doi.org/10.1016/j.lungcan.2023.107415
Rights and permissions
About this article
Cite this article
Alectinib. Reactions Weekly 1985, 29 (2023). https://doi.org/10.1007/s40278-023-50799-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-50799-8